Conference Call to Be Held at 8:30 a.m. Eastern TimePARSIPPANY, NJ, Feb 09, 2010 (MARKETWIRE via COMTEX) -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly
conference call for Wednesday, February 17, 2010 at 8:30 a.m. Eastern
Time to discuss fourth quarter and full year 2009 financial results,
operational developments, and outlook for 2010.
The conference call will be available via phone and webcast. The
dial in information is listed below:
Domestic Dial In: 800.599.9829
International Dial In: 617.847.8703
Passcode for both dial in numbers: 95981334
Replay is available from 11:30 a.m. Eastern Time following the
conference call through February 24, 2010. To hear a replay of the
call dial 888-286-8010 (domestic) and 617-801-6888 (international).
Passcode for both dial in numbers is 99158077.
This call is being webcast and can be accessed at The Medicines
Company website at www.themedicinescompany.com.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the
treatment of critical care patients through the delivery of
innovative, cost-effective medicines to the worldwide hospital
marketplace. The Company markets Angiomax(R) (bivalirudin) in the
United States and other countries for use in patients undergoing
coronary angioplasty, and Cleviprex(R) (clevidipine butyrate)
injectable emulsion in the United States for the reduction of blood
pressure when oral therapy is not feasible or not desirable. The
Company's website is www.themedicinescompany.com.
Contact:
Andreas Bremer
Senior Vice President and
Chief Business Officer
011 41 43 813 3335
investor.relations@themedco.com
SOURCE: The Medicines Company
mailto:investor.relations@themedco.com
